Aspira Pathlab & Diagnostics Limited

BSE:540788 Stock Report

Market Cap: ₹620.7m

Aspira Pathlab & Diagnostics Past Earnings Performance

Past criteria checks 0/6

Aspira Pathlab & Diagnostics has been growing earnings at an average annual rate of 21.4%, while the Healthcare industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 9.2% per year.

Key information

21.4%

Earnings growth rate

28.5%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate9.2%
Return on equity-18.8%
Net Margin-12.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Aspira Pathlab & Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:540788 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24152-1900
31 Mar 24132-2730
31 Dec 23128-2450
30 Jun 23141-500
31 Mar 23145-150
31 Dec 221651620
30 Sep 221682020
30 Jun 221662200
31 Mar 221954520
31 Dec 211823440
30 Jun 211964000
31 Mar 211521440
31 Dec 20131-450
30 Jun 2080-3850
31 Mar 2084-4250
30 Sep 1984-4490
30 Jun 1981-4900
31 Mar 1976-5290
31 Mar 1844-5680
31 Mar 178-2760
31 Mar 160010
31 Mar 150000

Quality Earnings: 540788 is currently unprofitable.

Growing Profit Margin: 540788 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 540788 is unprofitable, but has reduced losses over the past 5 years at a rate of 21.4% per year.

Accelerating Growth: Unable to compare 540788's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 540788 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (29.6%).

Return on Equity

High ROE: 540788 has a negative Return on Equity (-18.82%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:32
End of Day Share Price 2024/12/26 00:00
Earnings2024/06/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aspira Pathlab & Diagnostics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution